Date published: 2025-10-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Gm949 Inhibitors

Gm949 inhibitors belong to a class of small molecules that target the activity of Gm949, a protein with regulatory functions in various biochemical pathways. These inhibitors function by binding to the active or allosteric sites of the Gm949 protein, thereby altering its structural conformation and impeding its normal enzymatic activity. The interaction between Gm949 and its inhibitors is often governed by non-covalent interactions such as hydrogen bonding, hydrophobic interactions, and van der Waals forces, which allow for reversible binding. Structural analyses of Gm949 inhibitors typically reveal key functional groups that facilitate these interactions, often involving nitrogen- and oxygen-containing moieties that mimic the natural substrates or co-factors of the protein.

The chemical structures of Gm949 inhibitors vary widely, but many share common features, such as aromatic ring systems, heterocycles, or hydrophobic regions that enhance their binding affinity to Gm949. Additionally, these inhibitors are often characterized by high specificity, designed to avoid off-target effects on other proteins within related pathways. Modifications to the chemical backbone of these inhibitors can significantly influence their binding kinetics and the degree to which they inhibit Gm949 activity. Advanced synthetic chemistry techniques are employed to optimize the pharmacokinetics and bioavailability of these molecules, ensuring that they retain stability and effectiveness in different environments. These inhibitors are typically explored in laboratory settings to understand their role in modulating biochemical reactions where Gm949 is a key player, providing valuable insights into the molecular mechanisms governing cellular processes.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Disrupts ARF-related transport between the Golgi and ER, can affect Arl14epl's function if it relies on ARF proteins.

Golgicide A

1005036-73-6sc-215103
sc-215103A
5 mg
25 mg
$187.00
$670.00
11
(1)

Specific Golgi disruptor, inhibits GBF1, can interfere with Arl14epl if it is involved in Golgi function.

SecinH3

853625-60-2sc-203260
5 mg
$273.00
6
(1)

Inhibitor of cytohesins, can affect Arl14epl indirectly by altering ARF protein signaling.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$134.00
$502.00
7
(1)

Cdc42 inhibitor, can affect Arl14epl if it interacts with the Cdc42 signaling pathway.

Exo2

304684-77-3sc-215011
sc-215011A
5 mg
25 mg
$87.00
$282.00
1
(0)

Inhibitor of exocyst complex, can affect Arl14epl by altering vesicular trafficking.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$87.00
44
(2)

Dynamin inhibitor, can affect Arl14epl by inhibiting endocytosis and vesicle formation.

Pitstop 2

1419093-54-1sc-507418
10 mg
$360.00
(0)

Clathrin-mediated endocytosis inhibitor, can affect Arl14epl if it is involved in this pathway.

SMIFH2

340316-62-3sc-507273
5 mg
$140.00
(0)

Inhibitor of formin-mediated actin polymerization, can affect Arl14epl if it is related to actin dynamics.

CK 666

442633-00-3sc-361151
sc-361151A
10 mg
50 mg
$315.00
$1020.00
5
(0)

Inhibitor of the Arp2/3 complex, can affect Arl14epl by altering actin filament branching.

Latrunculin B

76343-94-7sc-203318
1 mg
$229.00
29
(1)

Actin polymerization inhibitor, can affect Arl14epl by disrupting actin cytoskeleton dynamics.